Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
US11292799B2 · kind B2 · utility
4Cited by
6References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 14, 2018 |
| Grant date | Apr 5, 2022 |
| Priority date | — |
| Expiry date | Mar 25, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel substituted azetidine dihydrothienopyrimidines with phosphodiesterase inhibitory activity, and to their use in therapy, and to pharmaceutical compositions comprising the compounds and to methods of treating diseases with the compounds (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.